139 related articles for article (PubMed ID: 7829272)
41. A synthetic peptide elicits antibodies reactive with the external glycoprotein of human T cell lymphotropic virus type I.
Lal RB; Rudolph DL; Palker TJ; Coligan JE; Folks TM
J Gen Virol; 1991 Sep; 72 ( Pt 9)():2321-4. PubMed ID: 1716657
[TBL] [Abstract][Full Text] [Related]
42. Detection of early human T-cell lymphotropic virus type I antibody patterns during seroconversion among transfusion recipients.
Manns A; Murphy EL; Wilks R; Haynes G; Figueroa JP; Hanchard B; Barnett M; Drummond J; Waters D; Cerney M
Blood; 1991 Feb; 77(4):896-905. PubMed ID: 1993227
[TBL] [Abstract][Full Text] [Related]
43. Laboratory characterization of human T cell lymphotropic virus types 1 (HTLV-1) and 2 (HTLV-2) infections in blood donors from Sao Paulo, Brazil.
Segurado AA; Malaque CM; Sumita LM; Pannuti CS; Lal RB
Am J Trop Med Hyg; 1997 Aug; 57(2):142-8. PubMed ID: 9288805
[TBL] [Abstract][Full Text] [Related]
44. Human T lymphotropic virus types I and II western blot seroindeterminate status and its association with exposure to prototype HTLV-I.
Yao K; Hisada M; Maloney E; Yamano Y; Hanchard B; Wilks R; Rios M; Jacobson S
J Infect Dis; 2006 Feb; 193(3):427-37. PubMed ID: 16388491
[TBL] [Abstract][Full Text] [Related]
45. Infection of rats with human T-cell leukemia virus type-I: susceptibility of inbred strains, antibody response and provirus location.
Ibrahim F; Fiette L; Gessain A; Buisson N; de-Thé G; Bomford R
Int J Cancer; 1994 Aug; 58(3):446-51. PubMed ID: 8050826
[TBL] [Abstract][Full Text] [Related]
46. Human T cell lymphotropic virus: necessity for and feasibility of a vaccine.
de Thé G; Bomford R; Kazanji M; Ibrahim F
Ciba Found Symp; 1994; 187():47-55; discussion 55-60. PubMed ID: 7796676
[TBL] [Abstract][Full Text] [Related]
47. Human T lymphotropic virus type 1 subtype C melanesian genetic variants of the Vanuatu Archipelago and Solomon Islands share a common ancestor.
Cassar O; Capuano C; Bassot S; Charavay F; Duprez R; Afonso PV; Abel M; Walter H; Mera W; Martin PM; Chungue E; Gessain A
J Infect Dis; 2007 Aug; 196(4):510-21. PubMed ID: 17624835
[TBL] [Abstract][Full Text] [Related]
48. A Potential of an Anti-HTLV-I gp46 Neutralizing Monoclonal Antibody (LAT-27) for Passive Immunization against Both Horizontal and Mother-to-Child Vertical Infection with Human T Cell Leukemia Virus Type-I.
Fujii H; Shimizu M; Miyagi T; Kunihiro M; Tanaka R; Takahashi Y; Tanaka Y
Viruses; 2016 Feb; 8(2):. PubMed ID: 26848684
[TBL] [Abstract][Full Text] [Related]
49. An HTLV-I/II vaccine: from animal models to clinical trials?
de Thé G; Kazanji M
J Acquir Immune Defic Syndr Hum Retrovirol; 1996; 13 Suppl 1():S191-8. PubMed ID: 8797723
[TBL] [Abstract][Full Text] [Related]
50. Effect of the recombinant vaccinia viruses that express HTLV-I envelope gene on HTLV-I infection.
Shida H; Tochikura T; Sato T; Konno T; Hirayoshi K; Seki M; Ito Y; Hatanaka M; Hinuma Y; Sugimoto M
EMBO J; 1987 Nov; 6(11):3379-84. PubMed ID: 2828027
[TBL] [Abstract][Full Text] [Related]
51. Combined cytolytic effects of a vaccinia virus encoding a single chain trimer of MHC-I with a Tax-epitope and Tax-specific CTLs on HTLV-I-infected cells in a rat model.
Ohashi T; Nakamura T; Kidokoro M; Zhang X; Shida H
Biomed Res Int; 2014; 2014():902478. PubMed ID: 24791004
[TBL] [Abstract][Full Text] [Related]
52. Vaccinia virus H3L envelope protein is a major target of neutralizing antibodies in humans and elicits protection against lethal challenge in mice.
Davies DH; McCausland MM; Valdez C; Huynh D; Hernandez JE; Mu Y; Hirst S; Villarreal L; Felgner PL; Crotty S
J Virol; 2005 Sep; 79(18):11724-33. PubMed ID: 16140750
[TBL] [Abstract][Full Text] [Related]
53. [Production of HTLV-II env protein and its suppressive effect on infection].
Kawamura N
Hokkaido Igaku Zasshi; 1995 Jul; 70(4):635-47. PubMed ID: 7590608
[TBL] [Abstract][Full Text] [Related]
54. Dual infection of rabbits with human T cell lymphotropic virus types I and II.
Machida H; Morishita N; Ikezoe T; Sawada T; Ohtsuki Y; Miyoshi I
Jpn J Cancer Res; 1997 Feb; 88(2):137-42. PubMed ID: 9119741
[TBL] [Abstract][Full Text] [Related]
55. [Confirmation of the presence in Cuba of human T-cell lymphotropic virus type I using the polymerase chain reaction].
Rolo Gómez F; De Armas MB; Mato Luis J; Lubián Caballero AL; Díaz Torres H
Rev Cubana Med Trop; 1997; 49(3):204-8. PubMed ID: 9685988
[TBL] [Abstract][Full Text] [Related]
56. Cross-neutralizing antibodies against cosmopolitan and Melanesian strains of human T cell leukemia/lymphotropic virus type I in sera from inhabitants of Africa and the Solomon Islands.
Benson J; Tschachler E; Gessain A; Yanagihara R; Gallo RC; Franchini G
AIDS Res Hum Retroviruses; 1994 Jan; 10(1):91-6. PubMed ID: 8179967
[TBL] [Abstract][Full Text] [Related]
57. Difficulties in the diagnosis of HTLV-2 infection in HIV/AIDS patients from Brazil: comparative performances of serologic and molecular assays, and detection of HTLV-2b subtype.
Morimoto HK; Morimoto AA; Reiche EM; Ueda LT; Matsuo T; Reiche FV; Caterino-de-Araujo A
Rev Inst Med Trop Sao Paulo; 2007; 49(4):225-30. PubMed ID: 17823751
[TBL] [Abstract][Full Text] [Related]
58. Induction of Heterologous Tier 2 HIV-1-Neutralizing and Cross-Reactive V1/V2-Specific Antibodies in Rabbits by Prime-Boost Immunization.
Townsley S; Mohamed Z; Guo W; McKenna J; Cleveland B; LaBranche C; Beaumont D; Shen X; Yates NL; Pinter A; Tomaras GD; Ferrari G; Montefiori DC; Hu SL
J Virol; 2016 Oct; 90(19):8644-60. PubMed ID: 27440894
[TBL] [Abstract][Full Text] [Related]
59. Protective immunity to vaccinia virus induced by vaccination with multiple recombinant outer membrane proteins of intracellular and extracellular virions.
Fogg C; Lustig S; Whitbeck JC; Eisenberg RJ; Cohen GH; Moss B
J Virol; 2004 Oct; 78(19):10230-7. PubMed ID: 15367588
[TBL] [Abstract][Full Text] [Related]
60. HTLV-1 sequences in lymphocytes of a patient with non-tropical spastic tetraparesis and her asymptomatic husband.
Manca N; Gelmi M; Mattioli F; Gargiulo F; Terlenghi L; Pirali F; Turano A
New Microbiol; 1993 Jan; 16(1):11-7. PubMed ID: 8469167
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
